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Over 250 people participated in a 2-day
conference, "Molecular Mechanisms of
Environmental Carcinogenesis," at the
National Institute of Environmental
Health Sciences (NIEHS) in Research
Triangle Park, North Carolina, 19-20
September 1994. The purpose ofthe con-
ference was to bring together scientists to
discuss recent advances in basic cancer
research, with an emphasis on the contri-
bution ofenvironmental factors to neopla-
sia. The conference was initiated with a
brief welcoming address by NIEHS
Director Kenneth Olden, and included 17
platform talks as well as a collection of
poster presentations.
The conference was divided into four
sessions. The first session focused on cell
cycle control and cancer. Normal cells
carefully monitor cell cycle events such as
DNA replication and cell division to main-
tain a stable genome. Failure to regulate
the cell cycle appropriately is a fundamen-
tal characteristic of cancer cells.
Elucidation of the molecular events
involved in cell cycle transitions, genetic
instability, and responses to DNA damage
is critical for understanding the impact of
the environment on carcinogenesis.
The fission yeast, Schizosaccharomyces
pombe, has provided an important model
system for the identification ofcheckpoint
genes. Mutants of S. pombe that fail to
undergo cell cycle arrest when DNA syn-
thesis is inhibited by hydroxyurea have
recently been identified. These mutants
proceed through mitosis and cell division
without completing DNA replication.
Because the molecules that control cell
cycle transitions in yeast have been con-
served through evolution, it will be of
interest to elucidate the function of these
new genes to ascertain their roles, ifany, in
mammalian cell checkpoint control.
The molecular details ofhow oncogenes
and tumor-suppressor genes function in
growth control are becoming clearer from
studies of the retinoblastoma susceptibility
gene product (pRB) and the product ofthe
c-ablAprosine kinase proto-oncogene,
p170 . Dominant-negative mutations in
Rb disrupt the interactions between pRb Abl and p170 , resulting in an inhibition of
the growth suppression function of pRb.
Recently, mutations have been generated in
Rb that prevent this growth-suppression
function from being blocked by phospho-
rylation. These and other results have been
used to suggest that pl70 can regulate
pRb complexes that in turn regulate entry
into and exit from the cell cycle, as well as
progression through DNAsynthesis.
The role of the p53 tumor-suppressor
gene product in cancer is of particular
interest because p53 is the most commonly
mutated gene in human cancers character-
ized to date. Cells that lack a functional
p53 cannot undergo cell cycle arrest in
response to DNA damage and will enter
DNA synthesis with unrepaired DNA.
The molecular dynamics of the cellular
response pathways that involve p53 in
response to DNA damage are currently
under intense scrutiny. DNA strand
breaks, induced by either ionizing radia-
tion or microinjection of a restriction
endonuclease, have been shown to lead to
an increase in p53. This increase requires
the currently undefined gene product(s)
that are defective in ataxia-telangiectasia, a
cancer-prone inherited disease. The induc-
tion ofp53 results in either cell cycle delay
or initiation of programmed cell death
(apoptosis), depending on the cell type. A
practical application of a better under-
standing ofthis pathway might be the spe-
cific induction of apoptosis in tumor cells
after exposure to therapeutic agents.
Cytoskeletal alterations and genomic
instability in cells transformed by the mos
oncogene were also discussed in the first
session. Murine fibroblasts infected with a
mos virus have elevated levels of mitogen-
activated protein (MAP) kinase activity and
displaced spindles that are abnormally
attached to the cell membrane during mito-
sis. The alteration in cytoskeletal compo-
nents in mos-transformed cells, as well as
inappropriate expression of certain mitotic
phenotypes in interphase cells, could con-
tribute to genomic instability in these cells,
thus providing a model system for the fur-
ther studyofgenomic instability in tumors.
The second session focused on cancer
susceptibility genes. For many years, it has
been clear that certain individuals and their
offspring are prone to develop specific
types ofcancers at an earlier age or with an
increased frequency compared to the gen-
eral population. With recent improve-
ments in DNA mapping strategies, along
with advances in molecular biological
techniques, scientists now can identify
defects in specific genes that are responsi-
ble for these familial cancers. Among the
relevant topics addressed at this conference
were epidemiological studies of cancer
prone families, characterization of a
recently identified breast cancer gene, the
role of heritable differences in xenobiotic
metabolism in cancer susceptibility, and
mouse models for the identification ofnew
cancer susceptibility genes.
Data from kindreds of patients who
develop soft tissue sarcomas early in life
revealed strong evidence for a dominantly
inherited cancer gene. Some of the
patients were characterized as having Li-
Fraumeni syndrome; their disease could be
linked to mutations in the p53 tumor-sup-
pressor gene. Recent studies have suggest-
ed an earlier age ofcancer onset in consec-
utive generations of families carrying p53
mutations. This interesting observation
could be due to improved screening and
detection methods, an increase in environ-
mental insults, or genetic instability associ-
ated with mutations in p53. Better moni-
toring and early detection of tumors will
be critical for families with mutations pre-
disposing them to cancer and should pro-
vide valuable insight into environmental
carcinogenesis. Two presentations focused
on the highly publicized breast cancer
gene, BRCAJ. One provided a historical
context ofthe identification ofthe BRCAJ
gene and its role in the development of
breast and ovarian cancers. BRCA1 is
thought to account for at least 85% of
families with increased incidence of both
early onset breast cancer and ovarian can-
cer. However, less than half the families
with site-specific breast cancer are linked
to BRCAJ. Several of the site-specific
breast cancer families that are not associat-
ed with BRCAJ are linked to a second
breast cancer susceptibility gene, BRCA2,
which has recently been localized to chro-
mosome 13q. A second presentation
described work performed by scientists at
NIEHS in collaboration with scientists at
the University of Utah and Myriad
Genetics on the molecular cloning of
BRCAJ and the characterization of muta-
tions in the gene. The BRCAI gene
encodes a relatively large protein of 1863
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amino acids with a RING finger motif in
its amino-terminal region. Characteriza-
tion of BRCAI may provide valuable
insights into breast cancer biology.
The interaction ofpro-carcinogens and
genetic variability was stressed in several
presentations. These included a discussion
of allelic differences in the activation of
chemical carcinogens by human
cytochromes P450 (CYP450) and glu-
tathione S-transferases with regard to their
role in cancer susceptibility. Individuals
with certain CYP450 alleles may be more
susceptible to metabolic activation of car-
cinogens. The combination ofgenetic vari-
ation and environmental exposure repre-
sents one example of the complexity evi-
dent in carcinogenesis, from initial expo-
sures to environmental pro-carcinogens to
the establishment of genetically unstable
tumors with highly malignant phenotypes.
Identification of polymorphisms in xeno-
biotic metabolism alleles associated with
increased incidence of cancer may enable
researchers to evaluate individual exposure
risks. One approach to unraveling these
complex interactions is to use animal mod-
els in which the combination of genetic
background and environmental exposure
can be controlled. Mouse models have also
been used to dissect tumor-susceptibility
genes involved in hepatocarcinogenesis.
For example, mice treated with the muta-
gen N,N-diethylnitrosamine showed a
100-fold difference in tumor multiplicity
depending on which inbred strain was
used. Such a strategy provides an experi-
mental approach for identifying multiple
genetic loci controlling the susceptibility to
liver tumors. At the meeting, it was pro-
posed that the promotion phase ofhepato-
carcinogenesis can be divided into a con-
version and a proliferation step. The use of
genetic studies to identify genes crucial for
the development of tumors should
improve our understanding of environ-
mental carcinogenesis.
The third session introduced the impor-
tance of hormones in carcinogenesis, with
an emphasis on estrogens. It is now clear
that estrogens cause cell proliferation in cer-
tain in vitrosystems and enhance tumor for-
mation in carcinogen-exposed animals.
However, estrogen effects in humans vary
by tissue type, exposure pattern, and subject
group. The relative risks ofendometrial and
breast cancer after estrogen exposure was a
topic of great interest. Many women are
nowexposed to estrogens, through oral con-
traceptives and estrogen replacement thera-
py, in a variety of doses and admixtures,
throughout their lives. This long-term expo-
sure makes the assessment ofrelative risk for
any single exposure much more difficult.
Furthermore, it was pointed out that the
baseline cancer rate in women changes with
age, and it is critical to take such changes
into account when judging the significance
ofanyapparent increase in relative risk.
The pathway by which estrogen
increases cancer risk was also addressed.
Important advances have been made in
defining the genetic alterations that charac-
terize estrogen-associated cancers, focusing
on endometrial carcinoma and clear-cell
adenocarcinoma of the vagina and cervix
resulting from exposure to diethylstilbe-
strol in utero. In addition to DNA
sequencing of tumor-suppressor genes, a
search for loss ofheterozygosity (LOH) has
been used to identify critical genetic ele-
ments. Clinical data have indicated that
LOH for human chromosome 14q is
closely associated with a poor prognosis in
patients with endometrial carcinoma. One
hope is that positional cloning will help
narrow the search for the genes involved.
Another set of genes now thought to be
critical to the regulation ofgenome stabili-
ty are those involved in DNA mismatch
repair. Microsatellite instability, observed
in a variety of tumor cells, also appears to
be present in as much as 10-20% of
human breast carcinomas. An analysis of
human mismatch repair genes, such as
-MSH2, is underway to see if inactivation
of key repair proteins is responsible for
genetic instability in various neoplasms.
Recent research has also explored estro-
gen-mediated changes in the control ofpro-
liferation by developing a series of variants
ofthe human breast cell line, MCF7. A fac-
tor in serum, called estrocolyone-1, has been
identified that specifically inhibits the pro-
liferation ofestrogen-sensitive cells. Variants
of.MCF7 have been generated that are no
longer inhibited by serum, but are inhibited
by estradiol. One ofthe implications ofthis
work for therapy is that the selective manip-
ulation of a patient's endocrine milieu can
be important for regulating growth ofestro-
gen-sensitive tumors.
The recognition ofprostate cancer as a
health issue for men has increased greatly
in the last decade: current estimates are
that 90% ofmen at age 80 will have some
level of hyperplastic prostate disease.
Research is in progress on the genetics and
cell biology of prostatic tumors, with the
goal of developing a set of tumor markers
that can be used reliably to diagnose the
severity of the disease. A model was pro-
posed in which a set of proteins involved
in cell-cell contact is inactivated, leading
to a loss of adhesion and increased metas-
tasis. These proteins include E-cadherin,
a-catenin, and f-catenin. Consistent with
this model, the introduction of chromo-
some 5 into a prostatic tumor cell line,
with a consequent expression of0a-catenin,
led to an increase in cell-cell contact. An
analysis offamilies manifesting higher inci-
dences of prostatic cancer, combined with
an analysis of metastasis-suppressor genes
in animal models, should enhance the abil-
ity to identify critical genes and to predict
the potential severity of disease discovered
in the early stages.
The final session of the meeting
focused on tumor-suppressor genes and
their biochemical functions. Studies of
pRB and its interactions with the EIA pro-
tein of adenovirus have provided clues to
the functions of these proteins in viral
transformation. The EIA protein has been
found to bind pRB and displace the E2F
transcription factor that is usually bound
by pRB. E2F DNA binding sites have been
identified in several genes known to be
involved in growth control. Thus, we can
now postulate mechanisms for how envi-
ronmentally induced mutations or viral
infection can lead to a loss ofgrowth con-
trol through the disruption ofspecific pro-
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tein-protein interactions. Furthermore, the
cloning of E2F homologues from
Drosophila melanogaster has allowed an
extensive analysis of E2F protein structure
and expression during embryogenesis and
may provide a useful marker for cells that
have recently undergone cell division.
It is clear that animal models will con-
tinue to be important tools for studying
the initiation and progression of cancers.
For example, a simple base change that
leads to a murine mutation, min (multiple
intestinal neoplasia), predisposes mice to
intestinal and mammary tumors. However,
the genetic background of the mouse in
which min is studied significantly alters the
expression of neoplasia. Genetic loci
termed mom, for modifier of min, have
been identified and mapped to mouse dis-
tal chromosome 4. The influence of car-
cinogens on the incidence of neoplasia in
strains with different genetic backgrounds
is underway and should allow a more com-
plete understanding of the interplay
between genetic predisposition and envi-
ronmental exposure.
Mutational spectra of tumor-suppres-
sor genes are being studied to reveal the
underlying patterns of spontaneous muta-
tion in these genes and the biological rele-
vance of specific mutations. Studies of a
large number of mutations in the Rb and
p53 genes indicated that the vast majority
of Rb mutations were nonsense errors,
whereas p53 mutations were diverse and
varied according to the tissue of origin.
One class of p53 G-to-T transversion
mutations was overrepresented and was
postulated to be the result ofenvironmen-
tal mutagen exposure. However, phenotyp-
ic selection for relevant mutations may
vary in different organs, and methodologi-
cal biases must be accounted for before
these spectra can be used to shed light on
the role ofspecific mutations in the etiolo-
gy ofcancer.
The importance ofrepair processes was
reiterated in a discussion of human muta-
tors hMSH2 and hMLH1. The presence of
multiple mutated genes in tumor cells has
led to the question ofhow cancer cells arise
given the usual low mutation rates in
eukaryotic cells. A number of proposals
have been made as to which kinds ofrepli-
cation and repair functions might be inacti-
vated to generate mutator phenotypes.
hMSH2 and hMLH1 belong to highly
conserved families of mismatch repair pro-
teins. Defects in these genes lead to increas-
es in mutation frequencies of up to 1000-
fold and enhanced rates of recombination.
In some tumors, including the hereditary
nonpolyposis colon cancer syndrome,
mutator phenotypes due to aberrant repair
may explain the observed increases in
microsatellite instability. Alterations in
other mutator genes may also play a critical
role in tumor development.
In summary, this conference provided
a strong reminder of the complexity of
cancer, a disease with both environmental
and genetic risk factors. The excitement
generated by the discovery of new genes
linked to familial disease was tempered by
the realization that any single gene may be
directly involved in a small percentage of
cancers. However, it may be expected that
the molecular and biochemical analysis of
such genes will provide insights into the
pathways by which processes such as cell
growth and cell-cell contact are disrupted.
Such an understanding should allow
researchers to seek out, in a logical fashion,
other candidate genes as well as environ-
mental agents that influence these path-
ways. Finally, a more complete description
of how these pathways are disrupted in
cancer cells may provide the knowledge to
develop effective preventive and therapeu-
tic strategies, based on clear biochemical
mechanisms and, ultimately, an improve-
ment in our ability to successfully treat
patients with cancer.
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